Abbott-Alere One Year Later: Was It Worth All the Fuss?

It's hard to believe it's been a full year since Abbott closed its acquisition of Alere, considering what a contentious deal it was and how hard Abbott fought last year to get out of it. When the acquisition finally did close, an MD+DI headline asked: Will All the Abbott-Alere Fuss Be Worth It?